Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

French Cyclkist Houanard Gets Two-Year Ban for EPO Use

Jan. 22 (Bloomberg) -- French cyclist Steve Houanard has been suspended for two years after testing positive for the banned substance Erythropoietin, or EPO, the International Cycling Union said.

The 26-year-old Ag2r-La Mondiale rider tested positive for the endurance-boosting drug during an out-of-competition test in September, the UCI said in an e-mailed statement today. Houanard has accepted his suspension, it said.

The UCI further said it has asked the Belgian National Cycling Federation RLVB to start a “disciplinary procedure” against rider Leif Hoste for a violation of anti-doping rules on the basis of his blood profile in his biological passport.

To contact the reporter on this story: Danielle Rossingh in London at

To contact the editor responsible for this story: Christopher Elser at

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.